RAVE: Radial Artery Vascular Complication and Resource Utilization

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 9, 2018

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
AngiogramPercutaneous Coronary Intervention
Interventions
DEVICE

RadAR EasyCLik plus ®-STF hemostatic pad

Chitosan-based, non-woven pad with a unique, proprietary fiber structure that when hydrated with tissue fluids forms a gel-like synthetic clot in conjunction with the RadAR EasyCLik compression device

DEVICE

TR BAND® Compression device plus ®-STF hemostatic pad

Chitosan-based, non-woven pad with a unique, proprietary fiber structure that when hydrated with tissue fluids forms a gel-like synthetic clot in conjunction with the TR BAND® compression device

DEVICE

SoftSeal®-STF hemostatic pad

Chitosan-based, non-woven pad with a unique, proprietary fiber structure that when hydrated with tissue fluids forms a gel-like synthetic clot

DEVICE

VascBand™ Hemostat

The VascBand™ Hemostat is an FDA-approved compression device designed to assist hemostasis of arterial, venous and hemodialysis percutaneous access sites.

Trial Locations (1)

53202

Aurora Health Care, Milwaukee

All Listed Sponsors
collaborator

Chitogen, Inc.

INDIV

lead

Wake Forest University Health Sciences

OTHER

NCT03522077 - RAVE: Radial Artery Vascular Complication and Resource Utilization | Biotech Hunter | Biotech Hunter